Cite
Prediction of presurgical metabolic syndrome for gastric cancer‐specific mortality is more evident in smokers: The FIESTA study.
MLA
Zhang, Xinran, et al. “Prediction of Presurgical Metabolic Syndrome for Gastric Cancer‐specific Mortality Is More Evident in Smokers: The FIESTA Study.” Cancer Medicine, vol. 12, no. 3, Feb. 2023, pp. 3419–32. EBSCOhost, https://doi.org/10.1002/cam4.5116.
APA
Zhang, X., Hu, D., Deng, X., Lin, J., Zheng, X., Peng, F., Meng, F., & Niu, W. (2023). Prediction of presurgical metabolic syndrome for gastric cancer‐specific mortality is more evident in smokers: The FIESTA study. Cancer Medicine, 12(3), 3419–3432. https://doi.org/10.1002/cam4.5116
Chicago
Zhang, Xinran, Dan Hu, Xiangling Deng, Jinxiu Lin, Xiongwei Zheng, Feng Peng, Fanqiang Meng, and Wenquan Niu. 2023. “Prediction of Presurgical Metabolic Syndrome for Gastric Cancer‐specific Mortality Is More Evident in Smokers: The FIESTA Study.” Cancer Medicine 12 (3): 3419–32. doi:10.1002/cam4.5116.